| Income statement (USD) | FY 2026 ended Jun 30, 2026 | FY 2025 ended Jun 30, 2025 | FY 2024 ended Jun 30, 2024 | FY 2023 ended Jun 30, 2023 | FY 2022 ended Jun 30, 2022 | FY 2021 ended Jun 30, 2021 |
|---|---|---|---|---|---|---|
| Revenue | 87.03B | 84.28B | 84.04B | 82.01B | 80.19B | 76.12B |
| Cost of revenue | 43.36B | 41.16B | 40.85B | 42.76B | 42.16B | 37.11B |
| Gross profit | 43.67B | 43.12B | 43.19B | 39.25B | 38.03B | 39.01B |
| Research and development | 2.10B | 2.10B | 2.00B | 2.00B | 2.00B | 1.90B |
| Selling, general and admin | 23.92B | 22.67B | 23.30B | 21.11B | 20.22B | 21.02B |
| Operating income | 19.75B | 20.45B | 18.55B | 18.13B | 17.81B | 17.99B |
| EBITDA | 22.91B | 23.30B | 21.44B | 20.85B | 20.62B | 20.72B |
| Interest expense | 877.00M | 907.00M | 925.00M | 756.00M | 439.00M | 502.00M |
| Income before tax | 20.38B | 20.17B | 18.76B | 18.35B | 18.00B | |
| Income tax | 4.23B | 4.10B | 3.79B | 3.62B | 3.20B | 3.26B |
| Net income | 16.05B | 15.97B | 14.88B | 14.65B | 14.74B | 14.31B |
| EPS | 6.75 | 6.67 | 6.18 | 6.07 | 6.00 | 5.69 |
| EPS (diluted) | 6.62 | 6.51 | 6.02 | 5.90 | 5.81 | 5.50 |
| Diluted shares | 2.42B | 2.45B | 2.47B | 2.48B | 2.54B | 2.60B |
| Dividends per share | 4.26 | 4.08 | 3.83 | 3.68 | 3.52 | 3.24 |
From Procter & Gamble's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.